R E A Holdings PLC
LSE:RE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R E A Holdings PLC
LSE:RE
|
UK |
|
A
|
Aarti Pharmalabs Ltd
NSE:AARTIPHARM
|
IN |
Balance Sheet
Balance Sheet Decomposition
R E A Holdings PLC
R E A Holdings PLC
Balance Sheet
R E A Holdings PLC
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
8
|
8
|
12
|
2
|
9
|
37
|
34
|
30
|
22
|
37
|
31
|
26
|
35
|
16
|
16
|
25
|
6
|
26
|
10
|
12
|
47
|
22
|
14
|
39
|
|
| Cash Equivalents |
8
|
8
|
12
|
2
|
9
|
37
|
34
|
30
|
22
|
37
|
31
|
26
|
35
|
16
|
16
|
25
|
6
|
26
|
10
|
12
|
47
|
22
|
14
|
39
|
|
| Short-Term Investments |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
2
|
10
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
4
|
7
|
7
|
6
|
3
|
2
|
0
|
1
|
3
|
5
|
3
|
4
|
2
|
25
|
5
|
10
|
2
|
16
|
5
|
3
|
3
|
5
|
5
|
2
|
|
| Accounts Receivables |
1
|
3
|
3
|
5
|
3
|
2
|
0
|
1
|
3
|
5
|
3
|
4
|
2
|
25
|
5
|
10
|
2
|
16
|
5
|
3
|
1
|
4
|
4
|
2
|
|
| Other Receivables |
3
|
4
|
4
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
|
| Inventory |
2
|
1
|
2
|
2
|
4
|
5
|
13
|
13
|
13
|
14
|
26
|
21
|
17
|
18
|
11
|
18
|
13
|
25
|
21
|
19
|
22
|
31
|
20
|
22
|
|
| Other Current Assets |
1
|
0
|
0
|
0
|
2
|
2
|
3
|
8
|
12
|
24
|
32
|
29
|
26
|
0
|
26
|
32
|
37
|
35
|
49
|
38
|
33
|
27
|
57
|
30
|
|
| Total Current Assets |
14
|
17
|
21
|
13
|
17
|
46
|
51
|
52
|
50
|
79
|
91
|
81
|
81
|
60
|
60
|
95
|
61
|
102
|
85
|
72
|
104
|
85
|
96
|
92
|
|
| PP&E Net |
73
|
80
|
90
|
100
|
136
|
172
|
208
|
243
|
276
|
307
|
347
|
411
|
435
|
459
|
469
|
472
|
482
|
407
|
433
|
416
|
409
|
399
|
343
|
445
|
|
| PP&E Gross |
73
|
80
|
90
|
100
|
136
|
172
|
208
|
243
|
276
|
307
|
347
|
411
|
435
|
459
|
469
|
472
|
482
|
407
|
433
|
416
|
409
|
399
|
343
|
445
|
|
| Accumulated Depreciation |
3
|
6
|
9
|
13
|
6
|
7
|
9
|
12
|
15
|
19
|
24
|
31
|
40
|
0
|
70
|
90
|
111
|
132
|
161
|
185
|
205
|
225
|
237
|
286
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
1
|
5
|
9
|
13
|
14
|
17
|
24
|
27
|
31
|
34
|
34
|
38
|
39
|
38
|
2
|
1
|
0
|
2
|
2
|
3
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
11
|
11
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
2
|
2
|
1
|
2
|
1
|
1
|
2
|
3
|
2
|
3
|
1
|
3
|
5
|
8
|
4
|
5
|
5
|
5
|
3
|
2
|
|
| Long-Term Investments |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
10
|
11
|
6
|
8
|
18
|
25
|
33
|
36
|
40
|
40
|
51
|
50
|
48
|
56
|
63
|
66
|
59
|
58
|
85
|
46
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
11
|
11
|
|
| Total Assets |
88
N/A
|
97
+11%
|
111
+14%
|
113
+2%
|
165
+47%
|
249
+51%
|
287
+15%
|
330
+15%
|
372
+13%
|
443
+19%
|
511
+15%
|
569
+11%
|
601
+6%
|
609
+1%
|
628
+3%
|
671
+7%
|
647
-4%
|
624
-4%
|
599
-4%
|
574
-4%
|
591
+3%
|
561
-5%
|
540
-4%
|
599
+11%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
2
|
1
|
1
|
1
|
3
|
5
|
3
|
6
|
6
|
4
|
7
|
11
|
4
|
18
|
8
|
12
|
12
|
21
|
28
|
15
|
16
|
10
|
12
|
7
|
|
| Accrued Liabilities |
4
|
4
|
7
|
3
|
1
|
3
|
3
|
4
|
5
|
6
|
9
|
17
|
12
|
0
|
11
|
15
|
19
|
14
|
13
|
8
|
8
|
11
|
15
|
20
|
|
| Short-Term Debt |
41
|
6
|
6
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
1
|
6
|
15
|
0
|
30
|
0
|
0
|
39
|
0
|
27
|
0
|
0
|
28
|
|
| Current Portion of Long-Term Debt |
8
|
8
|
9
|
1
|
4
|
22
|
3
|
11
|
2
|
9
|
3
|
2
|
36
|
42
|
51
|
29
|
39
|
15
|
34
|
61
|
24
|
22
|
32
|
23
|
|
| Other Current Liabilities |
2
|
3
|
5
|
4
|
8
|
1
|
4
|
3
|
12
|
12
|
13
|
6
|
4
|
12
|
12
|
17
|
32
|
25
|
23
|
29
|
37
|
21
|
19
|
17
|
|
| Total Current Liabilities |
57
|
22
|
27
|
13
|
17
|
31
|
14
|
24
|
24
|
30
|
36
|
37
|
62
|
86
|
81
|
103
|
101
|
74
|
136
|
113
|
112
|
64
|
78
|
96
|
|
| Long-Term Debt |
2
|
40
|
33
|
31
|
42
|
80
|
88
|
85
|
100
|
118
|
115
|
161
|
158
|
139
|
167
|
177
|
190
|
209
|
158
|
155
|
186
|
186
|
177
|
161
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
30
|
33
|
37
|
32
|
40
|
41
|
40
|
44
|
73
|
77
|
86
|
81
|
80
|
79
|
52
|
40
|
46
|
44
|
35
|
47
|
|
| Minority Interest |
6
|
7
|
8
|
9
|
11
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
23
|
18
|
14
|
13
|
20
|
21
|
24
|
14
|
71
|
|
| Other Liabilities |
1
|
0
|
1
|
5
|
0
|
0
|
0
|
27
|
14
|
18
|
16
|
12
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
1
|
10
|
17
|
0
|
|
| Total Liabilities |
66
N/A
|
69
+4%
|
69
0%
|
57
-17%
|
101
+76%
|
144
+43%
|
140
-3%
|
168
+21%
|
179
+6%
|
209
+17%
|
210
+0%
|
256
+22%
|
304
+19%
|
304
+0%
|
336
+11%
|
384
+14%
|
388
+1%
|
377
-3%
|
359
-5%
|
348
-3%
|
366
+5%
|
327
-11%
|
321
-2%
|
375
+17%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
13
|
14
|
19
|
26
|
26
|
38
|
38
|
41
|
43
|
61
|
88
|
83
|
86
|
0
|
105
|
105
|
117
|
117
|
134
|
134
|
134
|
134
|
134
|
134
|
|
| Retained Earnings |
5
|
10
|
13
|
20
|
43
|
68
|
90
|
94
|
120
|
159
|
200
|
197
|
171
|
213
|
187
|
162
|
135
|
114
|
85
|
71
|
70
|
78
|
63
|
70
|
|
| Additional Paid In Capital |
4
|
4
|
11
|
10
|
7
|
22
|
30
|
27
|
27
|
25
|
22
|
33
|
40
|
23
|
47
|
60
|
59
|
59
|
47
|
47
|
47
|
47
|
47
|
47
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
10
|
23
|
10
|
0
|
2
|
11
|
9
|
0
|
0
|
44
|
46
|
39
|
51
|
42
|
26
|
26
|
25
|
25
|
24
|
26
|
|
| Total Equity |
21
N/A
|
28
+31%
|
42
+51%
|
56
+33%
|
65
+16%
|
105
+62%
|
148
+41%
|
162
+10%
|
193
+19%
|
234
+21%
|
301
+29%
|
313
+4%
|
297
-5%
|
305
+3%
|
292
-4%
|
287
-2%
|
259
-10%
|
247
-5%
|
240
-3%
|
226
-6%
|
226
0%
|
234
+4%
|
220
-6%
|
224
+2%
|
|
| Total Liabilities & Equity |
88
N/A
|
97
+11%
|
111
+14%
|
113
+2%
|
165
+47%
|
249
+51%
|
287
+15%
|
330
+15%
|
372
+13%
|
443
+19%
|
511
+15%
|
569
+11%
|
601
+6%
|
609
+1%
|
628
+3%
|
671
+7%
|
647
-4%
|
624
-4%
|
599
-4%
|
574
-4%
|
591
+3%
|
561
-5%
|
540
-4%
|
599
+11%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
13
|
13
|
19
|
20
|
25
|
31
|
33
|
33
|
33
|
33
|
33
|
33
|
35
|
35
|
37
|
40
|
40
|
40
|
44
|
44
|
44
|
44
|
44
|
44
|
|
| Preferred Shares Outstanding |
6
|
6
|
6
|
6
|
9
|
11
|
14
|
15
|
16
|
27
|
44
|
50
|
52
|
59
|
64
|
64
|
72
|
72
|
72
|
72
|
72
|
72
|
72
|
72
|
|